Tag: Israel
-
Stem Cell Treatments Show Benefit for ALS Patients
A clinical trial testing the safety of treatments derived from patients’ stem cells shows patients with ALS were able to slow the progression of their disease.
-
Antibody Treatment Shown to Prevent Migraine
9 June 2016. A clinical trial shows an engineered antibody in one week reduced the number of headaches in people who experienced migraines for an average of 18 years. Results of the study testing the experimental treatment appear in yesterday’s issue of the journal Neurology, published by American Academy of Neurology. Migraine is a neurological syndrome…
-
Venture Firm Funding Univ. Blood Diagnostics Technology
23 May 2016. A life sciences venture capital company is funding development of a technology at an Israeli research lab using DNA from blood tests to diagnose a range of diseases. Aurum Ventures is providing $1.2 million to Hebrew University of Jerusalem, through its technology transfer affiliate Yissum Research Development Company, for the university lab…
-
ReWalk, Wyss Institute Developing Soft Exoskeleton Robot
17 May 2016. A robotics company is licensing technology from a bioengineering lab at Harvard University to develop systems for people needing help with mobility, such as those with multiple sclerosis or suffering a stroke. Financial aspects of the deal between ReWalk Robotics Ltd. in Yokneam Ilit, Israel and the Wyss Institute for Biologically Inspired…
-
Students Design Pad to Collect Urinary Infection Samples
14 January 2016. A team at Hebrew University in Jerusalem designed a microfiber pad to improve collection of urine samples from people with urinary tract infections. Graduate students from a number of disciplines developed the pad under in the Israeli university’s Biodesign medical innovation program. Infections can occur anywhere in the urinary tract, but happen…
-
Trials Show Safety, Benefit of Stem Cells to Treat ALS
11 January 2016. Two clinical trials testing stem cells to treat amyotrophic lateral sclerosis, or ALS, found the treatments are safe for patients, and can slow progression of the disease. Results of the trials testing the stem cell product known as NurOwn made by BrainStorm Cell Therapeutics in Petach Tikvah, Israel are reported today in…
-
Trial Underway Testing Flesh-Eating Bacteria Drug
7 December 2015. A late-stage clinical trial began enrolling patients to test a new treatment for rare, but dangerous bacterial infections that destroy soft tissue and muscle. The trial is testing AB103, a biologic therapy developed by the biotechnology company Atox Bio in Ness Ziona, Israel. AB103 is designed to treat necrotizing soft tissue infections,…
-
Winners of ALS Variation Models Challenge Announced
5 November 2015. Participants from universities in the U.S. and Taiwan are winners of a challenge to develop mathematical models that predict variations in progression of ALS in patients with the disease. The Dream ALS Stratification Prize4Life Challenge is a joint undertaking of Sage Bionetworks, a not-for-profit biomedical research organization, Dialogue on Reverse Engineering Assessment…
-
Allergan Acquires Depression Therapy Developer for $560M
27 July 2015. Pharmaceutical maker Allergan plc is acquiring Naurex Inc., a designer of fast-acting therapies for depression and other neurological disorders, for $560 million. The deal covers Naurex’s products now in clinical trials, with the company’s technology platform and preclinical research spun-off into a new enterprise. Naurex, a spin-off company from Northwestern University in…
-
Dental Implants Found Prone to Fractures
22 July 2015. A review of manufactured dental implants discarded because of bone loss in the jaw of their wearers, indicates more than 6 in 10 of the devices had cracks or similar mechanical defects. The findings from the study by Keren Shemtov-Yona, a dentist and engineering doctoral student at Technion-Israel Institute of Technology in…